Do you want to read an article? Please log in or register.
Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis
Related content
RECOMMENDED
Pneumonia
Risk factors and prophylaxis of Pneumocystis jirovecii pneumonia in HIV-negative patients
RECOMMENDED
COPDPneumonia
Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology & outcomes
Clin Microbiol Infect.
Bordon J, Slomka M, Gupta R, Furmanek S, Cavallazzi R, Sethi S, Niederman M, Ramirez JA, University of Louisville Pneumonia Study Group.
doi: 10.1016/j.cmi.2019.06.025.
Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?
Ann Intensive Care.
Grasselli G, Vergnano B, Pozzi MR, Sala V, D'Andrea G, Scaravilli V, Mantero M, Pesci A, Pesenti A
doi: 10.1186/s13613-017-0320-3
Interstitial Lung DiseasePneumonia
Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
Clin Exp Rheumatol.
Mecoli CA, Saylor D, Gelber AC, Christopher-Stine L
Pneumonia
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Int AIDS Soc
Atkinson A, Miro JM, Mocroft A, Reiss P, Kirk O, Morlat P, Ghosn J, Stephan C, Mussini C, Antoniadou A, Doerholt K, Girardi E, De Wit S, Kraus D, Zwahlen M, Furrer H, Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD.
doi: 10.1002/jia2.25726
RECOMMENDED
Pneumonia
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Int AIDS Soc
Atkinson A, Miro JM, Mocroft A, Reiss P, Kirk O, Morlat P, Ghosn J, Stephan C, Mussini C, Antoniadou A, Doerholt K, Girardi E, De Wit S, Kraus D, Zwahlen M, Furrer H, Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD.
doi: 10.1002/jia2.25726
RECOMMENDED
ARDSPneumonia
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
BMJ.
Mahévas M, Tran VT, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel TA, Lescure FX, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky JM, Michel M, Perrodeau E, Carlier N, Roche N, de Lastours V, Ourghanlian C, Kerneis S, Ménager P, Mouthon L, Audureau E, Ravaud P, Godeau B, Gallien S, Costedoat-Chalumeau N
doi: 10.1136/bmj.m1844.
RECOMMENDED
ARDSPneumonia
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years
Crit Care.
Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, Eder M, Welte T, Hoeper MM, Scherag A, David S
doi: 10.1186/s13054-018-2221-8.
COPD
Population exacerbation incidence contains predictive information of acute exacerbations in patients with chronic obstructive pulmonary disease in telecare
Int J Med Inform.
Kronborg T, Mark L, Cichosz SL, Secher PH, Hejlesen O
doi: 10.1016/j.ijmedinf.